BLCO - Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month | Benzinga
Eye health products company Bausch + Lomb Corp (NYSE:BLCO) is scheduled to release its fourth-quarter and full-year 2023 financial results on February 21, 2024.
According to data from Benzinga Pro, the company expected to report sales of $1.107 billion, with EPS of $0.17.
RBC Capital writes that the fourth quarter of 2023 will continue to be influenced by currency headwinds (~$6 million RBC estimates versus management guidance of ~$26 million).
Also Read: Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ’s Blink.
RBC Capital analysts Douglas Miehm and Sahil Dhingra expect Bausch + Lomb to report revenue of $1.159 billion and adjusted EBITDA of $224 ...